|
HIV-associated
Neuromuscular Weakness Syndrome
The objective of the current study was to investigate progressive,
severe neuromuscular weakness associated with lactic acidosis in
some HIV patients after exposure to nucleoside reverse transcriptase
inhibitors (NRTI).
HIV-associated
neuromuscular weakness syndrome (HANWS) was retrospectively identified
and classified based on the level of diagnostic certainty:
- possible (progressive weakness
owing to neuromuscular disease);
- probable (progressive neuromuscular
weakness with documented exclusion of confounding causes); or
- definite (progressive weakness
and electrophysiological or pathological evidence of neuromuscular
pathology).
Results
Of
69 patients identified with HANWS, 27 had definite HANWS, 19 probable,
and 23 possible.
In
44 patients with documented follow-up, 16 required intubation and
nine died. There was a marginal association between death and hyperlactatemia
(P = 0.061).
At
onset of neurological symptoms, 68 were receiving antiretroviral
therapy, including stavudine for 61 (89.7%). Serum lactate level
was elevated (> 2.2 mmol/l) in 30/37 (81%), with a trend towards
an association between hyperlactatemia and stavudine usage (P =
0.087).
In
25, neurological symptoms occurred after antiretroviral therapy
discontinuation (median, 14 days). Electrophysiological studies
(n = 24) indicated sensorimotor neuropathy in 20 patients and myopathy
in three.
Nerve
biopsy (n = 9) revealed axonal degeneration and inflammation in
three, mixed axonal and demyelinating lesions in three, and primary
axonal neuropathy in three. Of 15 muscle biopsies, three revealed
inflammation and four mitochondrial abnormalities.
Conclusions
A
severe neuromuscular weakness syndrome may occur in HIV-infected
individuals. The association with hyperlactatemia and NRTI exposure
supports mitochondrial toxicity as a pathogenesis.
In
some, the onset of neurological symptoms lagged significantly after
discontinuation of antiretroviral therapy, suggesting that different
etiological mechanisms may underlie these cases.
06/25/04
Reference
D
Simpson and others (for the HIV-associated neuromuscular weakness
syndrome). HIV-associated neuromuscular weakness syndrome. AIDS 18(10): 1403-1412. July 2, 2004.
More
News Articles on Central Nervous System
|